This study will involve collection of pseudonymized data from hospital-based data reporting at multiple international sites. Collating data from a large volume of patients with COVID-19 admitted in ICU across multiple international sites will enable investigation of whether obesity is a risk factor for complicated from of SARS-CoV-2 in adult patients and whether this association is independent of other cardiometabolic risk factors.
The COVID-19 pandemic is characterized by a high frequency of patients with severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2), who often require invasive mechanical
ventilation (IMV). Body mass index (BMI) was however rarely mentioned in early clinical
reports.
Disease severity gradually increased with body mass index (BMI) categories among patients
admitted in intensive care unit (ICU) for severe acute respiratory syndrome coronavirus-2
(SARS-CoV-2), the need for invasive mechanical ventilation (IMV), reaching 85% in patients
with class II or III obesity ( BMI > 35 kg/m2).
In summary, there is an urgent need for more evidence on the specific role played by obesity
in the development of COVID-19 complications, and more particularly of severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2)
Other: Patients admitted to Intensive Care Unit with SARS-CoV2
Patients admitted to Intensive Care Unit with SARS-CoV2
Inclusion Criteria:
- Participant is aged 18 years or over
- Has been admitted to ICU with COVID-19 disease.
- COVID-19 disease has been confirmed by PCR for SARS-CoV-2
- Height and weight or BMI on admission has been recorded
- Data has been collected in an ethical manner as part of a national database or
clinical auditing process approved by the local institution or collaboration
Exclusion Criteria:
-There are no exclusion criteria
Centre Hospitalier Régional & Universitaire de Lille (CHRU)
Lille, France
Francois Pattou, MD, Study Director
Centre Hospitalier Régional & Universitaire de Lille (CHRU)